Skorpios Trust - Insider Trading & Ownership

Entity
Company
Location
195 Arch. Makarios III Ave., Neocleous House, Limassol, Cyprus
Summary
The estimated value of insider holdings of Skorpios Trust is at least $128 M dollars as of April 18, 2024. Skorpios Trust is the 10%+ Owner of Stoke Therapeutics, Inc. and owns shares of Stoke Therapeutics, Inc. (STOK) stock worth about $126 M. Skorpios Trust is the Former 10% owner of Akero Therapeutics, Inc. and owns shares of Akero Therapeutics, Inc. (AKRO) stock worth about $2.01 M.
All Insider Reports
All Insider Reports

Ownership of Skorpios Trust

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
STOK Stoke Therapeutics, Inc. 10%+ Owner $126 M -$41.8 M -24.9% Apr 17, 2024
AKRO Akero Therapeutics, Inc. Former 10% owner $2.01 M Dec 1, 2022

Insider Transactions Reported by Skorpios Trust:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership